Fundraising Fox

Panome Bio

<UNKNOWN>, US · Founded 2022 · 3 known investors

panomebio.com ↗

Panome Bio provides multi-omics discovery services using mass spectrometry-based metabolomics and proteomics to identify biomarkers and generate mechanistic insights for research institutions and pharmaceutical companies. The company's proprietary MassID computational platform and integrated bioinformatics pipeline analyze complex omics data from small molecules, proteins, and transcriptomics.

AI & Machine LearningBiotechDeep Techin /panome-bio

Founders & leadership

DS
David SmollerDirector
DL
Deval LashkariDirector
AH
Alexander HerzickDirector
EW
Edward WeinsteinExecutive Officer, Director
TC
Tom CohenExecutive Officer
RC
Rob CaponeDirector

Investors · 3

BioGenerator VenturesSt. Louis · $50K – $250K
Telegraph Hill PartnersSan Francisco · $2M – $8M
Cultivation CapitalreportedSt. Louis · $100K – $3.5Mvia David Smoller · board

Reported raises · per SEC filings

Form D private placements
▶$6MraisedNov 2024 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David SmollerDirector
  • Tom CohenExecutive Officer
  • Rob CaponeDirector
  • Edward WeinsteinExecutive Officer, Director
  • Deval LashkariDirector
Offering amount
$6M
Amount sold
$6M
Minimum investment
$25K
First sale
Nov 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedFeb 2023 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David SmollerDirector
  • Deval LashkariDirector
  • Alexander HerzickDirector
  • Edward WeinsteinExecutive Officer, Director
  • Tom CohenExecutive Officer
  • Rob CaponeDirector
Offering amount
$6M
Amount sold
$6M
Minimum investment
$20K
First sale
Feb 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.